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ABSTRACT
The purpose of this 30-day feeding study was to elucidate the changes, correlations, and mechanisms caused
by the replacement of the starch content of the AIN-93G diet (St) with glucose (G), fructose (F) or lard (L) in
body and organ weights, metabolic changes and caecal microbiota composition in rats (Wistar, SPF). The
body weight gain of rats on the F diet was 12% less (P 5 0.12) than in the St group. Rats on the L diet
consumed 18.6% less feed, 31% more energy and gained 58.4% more than the animals on the St diet,
indicating that, in addition to higher energy intake, better feed utilisation is a key factor in the obesogenic
effect of diets of high nutrient and energy density. The G, F and L diets significantly increased the lipid
content of the liver (St: 7.01 ± 1.48; G: 14.53 ± 8.77; F: 16.73 ± 8.77; L: 19.86 ± 4.92% of DM), suggesting
that lipid accumulation in the liver is not a fructose-specific process. Relative to the St control, specific
glucose effects were the decreasing serum glucagon (–41%) concentrations and glucagon/leptin ratio and the
increasing serum leptin concentrations (þ26%); specific fructose effects were the increased weights of the
kidney, spleen, epididymal fat and the decreased weight of retroperitoneal fat and the lower immune
response, as well as the increased insulin (þ26%), glucagon (þ26%) and decreased leptin (–25%) levels. This
suggests a mild insulin resistance and catabolic metabolism in F rats. Specific lard effects were the decreased
insulin (–9.14%) and increased glucagon (þ40.44%) and leptin (þ44.92%) levels. Relative to St, all diets
increased the operational taxonomic units of the phylum Bacteroidetes. G and L decreased, while F increased
the proportion of Firmicutes. F and L diets decreased the proportions of Actinobacteria, Proteobacteria and
Verrucomicrobia. Correlation and centrality analyses were conducted to ascertain the positive and negative
correlations and relative weights of the 32 parameters studied in the metabolic network. These correlations
and the underlying potential mechanisms are discussed.
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INTRODUCTION
An alarming incidence of metabolic illnesses (obesity and type 2 diabetes) has been observed
over the past four decades in the United States (Mokdad et al., 2001) and also in other
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affluent societies. This rise has occurred parallel to sedentary
lifestyle, the consumption of foods of high energy density
and the extensive use of high-fructose sweeteners. An
increasing number of evidences suggest that, among other
nutritional factors, high fructose consumption may play a
significant role in obesity (Bray et al., 2000) and the type 2
diabetes epidemic (Ang and Yu, 2018).
High-fat diets are a strong contributor to the obesity
epidemic and related co-morbidities (Mendoza et al., 2007);
however, there are data suggesting that ‘replacing carbohy-
drates with any fat, but particularly polyunsaturated fat, will
lower triglyceride (TG), increase high-density lipoprotein
(HDL) cholesterol, and lower blood pressure, but have no
effects on fasting glucose in normal volunteers or insulin
sensitivity, as assessed by euglycaemic hyperinsulinaemic
clamps’ (Clifton, 2019).
Another important factor influencing obesity is the
composition of the intestinal microbiota. Microbiota trans-
plantation from an overweight adult twin to germ-free mice
led to increased body fat mass, while mice receiving the lean
twin microbiota maintained normal weight (Ridaura et al.,
2013). The microbiota of genetically obese and lean mice on
the same carbohydrate-rich diet was significantly different in
the reduced abundance of Bacteroidetes and increased
abundance of Firmicutes in obesity (Ley et al., 2005). It is a
documented fact that diets influence both the gut microbiota
(Turnbaugh et al., 2009) and the immune system (Cianci
et al., 2018); however, the effects of specific macronutrients
need further clarification.
The aim of this study was to determine the special effects
of the nutrients glucose, fructose, and lard replacing the
starch content of the AIN-93G diet (control), at constant
nutrient/energy ratios, on feed intake, body weight gain, feed
conversion ratio, immune response, metabolomics and the
distal gut microbiota and their metabolic interrelationships.
While there are other studies looking at the effects of nu-
trients on each of the parameters cited, this is, to our
knowledge, the first comprehensive study investigating the
correlations and metabolic network significance among all
these parameters. A more complete understanding of these
interrelationships may contribute to unravelling metabolic
syndrome associated disease and nutrient interactions.
MATERIALS AND METHODS
This experiment was approved by the Animal Welfare
Committee of the University of Veterinary Medicine, Buda-
pest, Hungary. Ethics approval number: 53/2013 in agree-
ment with the permission of the Hungarian Scientific Ethics
Council for Animal Research (project no. 22.1/5/003/2010).
Animals and diets
Thirty-two 10-week-old male Wistar SPF rats, weighing
200–275 g, were divided into four groups with similar
average starting body weights (avg. 241.71 ± 17.66 g). The
animals were individually housed in wire-bottom cages
[light cycle 12 h on (7 a.m.–7 p.m.) 12 h off (7 p.m.–7 a.m.)].
The experimental diets were fed for 30 days. Water and feed
were provided ad libitum during the experiment.
Design of diets
The AIN-93G formula of the American Institute of Nutri-
tion (Reeves, 1997) was used as a starch-containing control
diet (St diet). In two diets the starch content of this formula
was replaced by either glucose or fructose (G and F diets)
(Table 1). In the case of the fourth diet the starch content of
Table 1. Composition of the experimental dietsp
Starch (St) Glucose (G) Fructose (F)
Lard (L)
(g and %) (g) (%)
Casein 10.00 10.00 10.00 10.00 15.65
Milk protein isolate 10.00 10.00 10.00 10.00 15.65
Cellulose 5.00 5.00 5.00 5.00 7.83
AIN93VX mineral premix 3.50 3.50 3.50 3.50 5.48
AIN93VX vitamin premix 1.00 1.00 1.00 1.00 1.57
Cyst, met, choline 0.50 0.50 0.50 0.50 0.78





Sum total 100.00 100.00 100.00 63.89 100.00
Calculated crude protein content (g/100
g diet)
16.89 16.89 16.89 26.43
Calculated energy content (MJ GE/100
g diet)
1.60 1.60 1.60 2.50
Protein/Energy ratio (g/MJ) 10.55 10.55 10.55 10.55
GE 5 gross energy; pThe energy and protein contents of the diets were calculated on the basis of the energy and the protein contents
declared by the raw material manufacturer.
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the AIN-93G formula (65 g/100 g diet 5 1,086.8 kJ) was
replaced by an energetically equivalent quantity of lard
(28.89 g 5 1,086.8 kJ) (L diet). Finally, the different in-
gredients of the L diet were expressed as a percentage of the
total weights of the calculated formula (Table 1).
Replacing carbohydrate with lard significantly increased
the energy density of the feed (1.6 versus 2.5 MJ GE/100 g
diet), but the protein and other nutrients/energy ratios
remained identical with that of the other three carbohydrate-
containing diets (10.55).
This significant difference in energy density at constant
nutrient/energy ratios allowed us to estimate the influence of
dietary energy density on feed and energy intake and on feed
conversion ratio.
Blood, plasma and serum samples
Blood, plasma or serum samples were collected in glass tubes
(heparinised for plasma), kept on ice, and then centrifuged
(4 8C, 10 min, 492 RCF) to obtain the plasma or serum
fraction.
Tested parameters
The following parameters were investigated in this experi-
ment: feed intake, body weight gain (BWG), eviscerated
body weight (EVSCBW), feed/gain, organ weights (liver,
kidney, spleen and adrenals), the epididymal and retroper-
itoneal white adipose tissues, serum glucose, fructosamine,
total cholesterol, TG, lactate dehydrogenase (LDH), insulin,
glucagon, leptin, antibody titre and the caecal microbiota.
Body weight, eviscerated body weight (EVSCBW), feed
intake and organ weights
Body weight and feed consumption were measured three
times a week, between 8:00 and 10:00 in the morning.
On the 30th day of the trial the rats were anaesthetised
with sodium pentobarbital (35 mg/kg BW) and exsangui-
nated via the vena cava caudalis between 8 and 11 a.m.
following a sequence that randomised the treatment groups.
After the removal of the viscera the EVSCBW and the
weights of the liver, kidneys, adrenals, epididymal and
retroperitoneal fat pads were measured.
Biochemical parameters
The glucose, total cholesterol, triglyceride (TG) and fruc-
tosamine concentrations, and LDH activity of the serum
samples were determined by an automated fluid chemical
analyzer (Olympus 400, Olympus, Hamburg, Germany) in
the Diagnostic Laboratory of the University of Veterinary
Medicine, Budapest, Hungary.
Hormones
Insulin, glucagon and leptin concentrations of the blood
serum were analysed by a ROCHE Cobas e 411 fully auto-
mated immunoassay analyzer, using Rat Leptin ELISA Kit
(Sigma, RAB0335), Rat Ins1/Insulin ELISA Kit (Sigma,
RAB0904) and Rat Glucagon EIA Kit (RayBioTech, P06883)
for serum, plasma and cell culture supernatant, in the
Biochemical Laboratory of DRC Ltd. (Drug Research Centre,
Balatonf€ured).
Immune response
On the first and 14th day of the experiment, the animals were
immunised with 0.2 mL ovalbumin solution (50 mg oval-
bumin þ 100 mL incomplete Freund’s adjuvant (IFA) þ 100
mL PBS/rat) intraperitoneally. The antibody titres of the blood
samples (collected on the 14th and 30th days of the experi-
ment) were analysed using ELISA (Vucskits et al., 2010).
DNA extraction and metagenomics library preparation
Caecal contents were collected soon after exsanguination.
The samples were stored at 5 8C until DNA extraction,
which took place within 5 h after sampling. To study the
effect of macronutrients on the microbiota, a shotgun DNA
sequencing method was used.
One gram aliquots of caecal content from each of the
eight rats per treatment group were pooled and analysed.
Total DNA was extracted from the isolated caecal contents
using the ZR Fecal DNA Kit from Zymo Research. The
isolated total genomic DNA samples were sequenced using
an Ion Torrent PGM platform (Life Technologies, Thermo
Scientific) according to the manufacturer’s recommenda-
tions. Fragment libraries were generated using Ion Xpress
Plus Fragment Library Kit. Ion Shear Plus Reagents Kit was
implemented for adapter ligation and nick translation.
Platinum PCR SuperMix, ION Library TaqMan qPCR and
Ion PGM 200 Xpress template kits were used for library
amplification, quantification and for the emulsion PCR,
respectively. Sequencing was performed on Ion 318 chips,
generating 150 k – 520 k high-quality reads per sample with
an average read length of 208 ± 87 bp.
Bioinformatic analysis
Quality-based filtering and trimming was performed by the
Trimmomatic sequence analysis tool (Bolger et al., 2014);
(with settings HEADCROP:12 CROP:320 LEADING:3
TRAILING:3 SLIDINGWINDOW:30:15 MINLEN:50) only
readings longer than 50 bp were retained. The Rattus nor-
vegicus genome sequences as host contaminants were filtered
out by Bowtie2 (version 2.3.5) (Langmead and Salzberg,
2012) with very-sensitive-local setting minimising the false
positive match level (Czajkowski et al., 2019) in further
metagenome classification. The remaining reads after
deduplication by VSEARCH (version 2.15.2) (Rognes et al.,
2016) were taxonomically classified using Kraken2 (version
2.0.9-beta) (k 5 35) (Wood et al., 2019) with the NCBI non-
redundant nucleotide database (Pruitt et al., 2005). The
Kraken reports were converted to biom structure by the tool
kraken-biom. For further steps of the taxon classification
data processing the phyloseq and microbiota R packages
were used. The alpha diversity was expressed by the Shan-
non index.
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Statistical analysis
For the interpretation of the results, as a gold standard, the data
from rats on the St diet were used as a basis for comparison.
Statistical analysis was performed using SPSS version 18.0
(IBM SPSS Statistics, 2016), which included ANOVA followed
by post hoc LSD and polynomial regression analysis. In the
presented networks the nodes are the variables. The networks
were built based on the correlation of the parameters. All
parameter pairs were correlated, and the statistic was tested
(Myles and Wolfe, 1973). Below the P < 0.05 threshold, the
variables are connected independently by the correlation di-
rection. These connections are represented by edges in the
graphs. The analysis was performed by the R-environment (R
Core Team, 2016) (R: A Language and Environment for Sta-
tistical Computing). Centrality (the weight of the nodes) was
analysed by the yEd Graph Editor (yEd Graph Editor, 2012).
In network science, centrality is a measure of the importance
of the nodes composing the network.
Because we measured pooled samples for DNA extrac-
tion (8 rats/treatment group and 1 g of caecal content from
each rat), the data of microbiome investigations are not
supported by statistical analysis. The heatmap was generated
by R-package pheatmap (Kolde, 2018).
RESULTS AND DISCUSSION
Feed and energy intake, body weight gain, feed
conversion ratio and abdominal white adipose tissues
Feed and energy intake. The data indicate (Table 2 and
Fig. 1) that the feed and energy intakes of rats on the three
Table 2. Specific effects of nutrients and energy density on the studied parameters
Starch (St) Glucose (G) Fructose (F) Lard (L)
Nutritional parameters ± STD
Energy density of the diets (kJ/g gross
energy)
16.32 16.32 16.32 25.52
Feed intake (g/100 g BW/day) 7.80 ± 1.10a 7.53 ± 0.23a 7.68 ± 0.89a 6.35 ± 0.37b
Energy intake (GE kJ/100 g BW/day) 124.3 ± 17.6a 122.6 ± 3.8a 125.5 ± 14.6a 162.8 ± 9.6b
BW gain (g/100 g BW/day) 1.33 ± 0.25a 1.30 ± 0.17a 1.17 ± 0.36a 2.11 ± 0.49b
Feed/gain (g/g) 5.86 ± 0.36a 5.78 ± 0.76a 6.56 ± 0.79a 3.01 ± 0.60b
Eviscerated body weight (EVSCBW) (g) 278.1 ± 9.9a 264.5 ± 19.2b 259.7 ± 20.2b 320.0 ± 15.3c
Fat pads
Epididymal (% of EVSCBW) 0.82 ± 0.31a 0.84 ± 0.28a 0.91 ± 0.26a
p
1.32 ± 0.41b




Liver (g/100 g BW) 3.47 ± 0.27a 3.95 ± 0.48b 4.30 ± 0.65b 3.50 ± 0.31a
Kidney (g/100 g BW) 0.68 ± 0.04a 0.68 ± 0.06a 0.77 ± 0.06b 0.63 ± 0.04c
Spleen (g/100 g BW) 0.27 ± 0.05a 0.30 ± 0.05ab 0.34 ± 0.07b 0.28 ± 0.06a
Adrenals (mg/100 g BW) 22.00 ± 6.00a 24.88 ± 8.94b 25.00 ± 5.29b 21.75 ± 2.6a
Chemical composition of the liver
Ash (% of DM) 6.67 ± 0.84a 7.24 ± 2.24a 7.13 ± 1.25a 5.90 ± 1.28b
Ether Extract (% of DM) 7.01 ± 1.48a 14.53 ± 8.77b 16.73 ± 8.77b 19.86 ± 4.92b
Crude protein (% of DM) 74.52 ± 3.32a 68.56 ± 7.97b 67.02 ± 6.18b 69.12 ± 4.49b
N-free extract (% of DM) 11.63 ± 3.80a 8.73 ± 7.49ab 9.63 ± 4.57a 4.70 ± 3.20b
Metabolomics
Serum glucose (mmol/L) 7.58 ± 1.23a 9.82 ± 3.11b 8.36 ± 1.51c 8.45 ± 1.27bc
Fructosamine (mmol/L) 455.4 ± 43.6a 488.3 ± 88.0a 398.4 ± 38.2b 464.4 ± 37.6a
Total cholesterol (mmol/L) 1.59 ± 0.18a 1.27 ± 0.27b 1.61 ± 0.28a 2.10 ± 0.32c
Triglyceride (mmol/L) 1.11 ± 0.29a 1.44 ± 0.54b 1.91 ± 0.56c 0.93 ± 0.20d
LDH (U/mL) 1.75 ± 0.60a 1.64 ± 0.84ab 1.84 ± 0.78ab 1.53 ± 0.37b
Insulin (mg/L) 1.86 ± 0.56a 1.97 ± 0.74ab 2.74 ± 1.85ab 1.69 ± 0.46b
Glucagon (pg/mL) 4.08 ± 3.20a 2.37 ± 1.28b 5.14 ± 4.20c 5.73 ± 2.03c
Leptin (ng/mL) 1.87 ± 0.78abc 2.34 ± 1.25a 1.40 ± 0.36b 2.71 ± 1.33c
Immune response
Antibody titre (14th day) (Log2) 10.64 ± 1.41 11.42 ± 1.18 10.52 ± 0.99 9.59 ± 1.66
Antibody titre (30th day) (Log2) 14.02 ± 1.69ab 14.36 ± 1.98b 13.27 ± 1.06ac 12.89 ± 1.04c
Ratios
Insulin/Glucagon 0.46 0.83 0.53 0.30
Insulin/Leptin 0.99 0.84 1.96 0.62
Glucagon/Leptin 2.18 1.01 3.67 2.11
STD 5 standard deviation. Different letters indicate statistically significant differences (P < 0.05) between the treatment groups; pindicates
significant difference between the epididymal and the retroperitoneal fat pads in rats on fructose diets.
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carbohydrate diets (St, G, and F) were statistically identical,
suggesting that the satiety effects of these carbohydrate diets
were the limiting factor of feed intake. In contrast, the rats
on the energy- and nutrient-dense L diet consumed signif-
icantly less feed (–18.7%) and more energy (þ30.9%) than
the rats on the starch control diet (Table 2).
This result is consistent with the data of Stubbs et al.
(2000), who suggest that energy density exerts profound
effects in constraining energy intake as a major factor and
influences appetite. Dietary macronutrients exert differential
effects on food and energy intake and the energy densities of
diets are more effective at increasing energy intake than at
decreasing food intake. In the current experiment the per-
centage increase of energy density of the lard diet over the
starch diet was numerically identical with the improvement
of body weight gain (58.4%).
Body weight gain. Feeding the F diet resulted in 12% less
body weight gain than that of rats on the St diet, and the
difference was close to the statistically significant level (P 5
0.120) (Fig. 1). This effect is in accordance with the result of
Mahmood et al. (2019), i.e. that fructose in the drinking
water decreases the body weight gain of rats compared to
water-treated control animals.
In contrast to this, rats on the nutrient- and energy-
dense L diet gained 58.4% more than the control animals on
the starch diet. This result is consistent with that reported by
Bhandari et al. (2011).
Feed conversion ratio. The feed conversion (feed/gain) ratio
(Table 2 and Fig. 1) for the three carbohydrate diets was not
different statistically. The feed conversion ratio of the lard
diet was significantly better than that of the carbohydrate
diets.
The facts that the rats on lard diet consumed 16% less
feed, 31% more energy and gained 58.4% more than the
control animals on the starch diet indicate that better
nutrient utilisation may be a key factor in explaining the
obesogenic effect of diets of high energy density.
Eviscerated body weight. Compared to the St diet, the G
and F diets significantly decreased (–4.9 and –6.6%,
respectively), while the L diet increased (þ15.1%) the
EVSCBW, suggesting that in rats on the G and F diets the
distribution of the synthesised body mass shifted toward the
visceral fat stores (Fig. 2).
Retroperitoneal and epididymal adipose tissues. Table 2
and Fig. 2 summarise the specific effects of macronutrients
on the abdominal adipose tissues.
The combined weight of epididymal and retroperitoneal
fat pads of rats on the isocaloric glucose or fructose diets
showed no difference from that of rats on the starch diet.
This is consistent with the fact that there was no significant
difference in weight gain either among these treatment
groups. Diet G did not influence, while diet F slightly but not
significantly increased the weight of the epididymal (þ10%)
fat pad. Both monosaccharides decreased the weight of
retroperitoneal adipose tissues (glucose: –6.9%), and the
effect of fructose was close to the significant level (–27.3%;
P 5 0.098). Other studies reported just the opposite of these
results, namely that fructose significantly increased the
weight of the retroperitoneal adipose tissue over the control
values (Zubiria et al., 2016). They observed that the retro-
peritoneal adipose tissue increased after eight weeks on a
fructose-enriched diet; this depended on the combined
accelerated adipogenesis and adipocyte hypertrophy, partly
due to the direct effect of fructose on adipocyte precursor
cells.
In an 8-week-long experiment with rats on isocaloric
high-fructose or control diets, Crescenso et al. (2014)
detected a significantly increased weight of the epididymal
and mesenteric white adipose tissues of rats in the high-
fructose group.
In the current experimental model, the weight of
epididymal and retroperitoneal adipose tissue was influ-
enced by the F diet in the opposing direction, and the dif-
ference between them was significant (P < 0.001).
Compared to the carbohydrate diets, the L diet of high
energy density induced a significant increase in the weights
of both the epididymal (þ60.1%) and the retroperitoneal
(þ81.3%) white adipose tissue. Other authors (Talarico
Fig. 1. Effect of diets on feed intake, energy intake, body weight
gain and feed/gain ratio. Different letters indicate significant dif-
ferences among the treatment groups at P < 0.05
Fig. 2. Effect of diets on eviscerated body weight (EVSCBW) and
epididymal and retroperitoneal fat pads. Different letters indicate
significant differences among the treatment groups at P < 0.05.
pindicates significant difference between the weight change of the
epididymal and retroperitoneal fat pads
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et al., 2020) reported that a diet high in unsaturated fat
increased the weight of the retroperitoneal adipose tissue
(12.9 ± 3 g) over the control (6.7 ± 1 g) and the saturated fat
diet groups (7.7 ± 1 g). Both high-fat groups increased the
weight of the epididymal adipose tissue (control diet: 5.8 ±1
g; saturated fat diet: 8.2 ± 1 g; unsaturated fat diet: 10.9 ± 3
g).
In their review, Bjørndal et al. (2011) suggest that ‘adi-
pose tissue metabolism is closely linked to insulin resistance,
and differential fat distributions are associated with disor-
ders like hypertension, diabetes, and cardiovascular disease’.
Specific effects of macronutrients on organ weights
Our working hypothesis was that fructose would affect or-
gans that have GLUT-5 fructose transporter and the keto-
hexokinase (KHK-C) enzyme; these organs are the small
intestine, the liver, the kidney and the pancreas (Diggle et al.,
2009). The other organs and the muscles have the KHK-A
enzyme which has a much higher Km than KHK-C, and
consequently the cells of these organs can metabolise fruc-
tose when its plasma concentration is high, making these
latter organs less sensitive to the detrimental effects of
fructose.
The G diet significantly increased the weight of the liver
and the adrenals but not that of the spleen (Table 2). The F
diet significantly increased the weight of the liver, kidney,
spleen, and adrenals; however, the latter two organs have no
GLUT5 transporter, thereby partially negating our working
hypothesis.
The function of the spleen is to filter the blood, detect
potentially dangerous microorganisms and thereby elicit an
immune response (Mebius and Kraal, 2005). A high dietary
level of monosaccharides (glucose or fructose) may influence
the gut microbiota and may increase intestinal permeability,
lipopolysaccharide (LPS) absorption and the development of
metabolic endotoxaemia (Do et al., 2018), thereby resulting
in spleen enlargement. Increased plasma uric acid levels,
inherent in fructose metabolism, may also cause adrenal
enlargement. The hypothalamic–pituitary–adrenal axis can
be stimulated by the purine metabolites that are rapidly
formed during the metabolism of fructose. Indeed, there is
evidence that a high-fructose diet significantly increases
serum uric acid (Caliceti et al., 2017) and corticosterone
(Harell et al., 2015) levels and may alter the function of the
hypothalamic–pituitary–adrenal axis.
Earlier findings further strengthen this speculation,
considering that adenosine and its metabolites (except for
hypoxanthine) significantly increase plasma corticosterone
level (Szabo et al., 1995) and may play a significant role in
the control mechanisms of the hypothalamic–pituitary–ad-
renal axis (Szabo and Bruckner, 1995). Based on clinical and
animal studies, excess glucocorticoids have been implicated
in the pathogenesis of non-alcoholic fatty liver disease
(NAFLD). Patients with NAFLD seem to have a subtle
chronic activation of the hypothalamic–pituitary–adrenal
axis leading to a state of subclinical hypercortisolism
(Papanastasiou et al., 2017).
Currently there is no explanation as to why the glucose
diet increased adrenal weight. Fructose and sucrose may also
induce renal hypertrophy and tubulointerstitial disease in
rats (Kretowicz, 2011).
The lard diet of high energy density increased the evis-
cerated body weight of rats (Table 2) but did not influence
the weight of the liver, spleen, or adrenals; interestingly, it
significantly decreased the weight of the kidney. This con-
tradicts the result of Altunkaynak et al. (2008) who found
significantly increased kidney volume and histopathological
renal deformities in rats on a high-fat diet; the fat source of
their diet was unclear. It is clear that the effects of a lard diet
on the weight of the studied organs are strikingly different
from those of glucose and fructose.
Chemical composition of the liver
To get more insight into the specific effects of macronutri-
ents on the liver, the chemical composition of the liver was
analysed (Table 2 and Fig. 3). The effects of the G and F diets
were practically the same.
The most significant effects of the G and F diets were the
dramatic increases of the liver fat content and the significant
decrease of liver protein content.
The decrease of nitrogen-free extract, most likely glucose
and glycogen (Szabo et al., 2018) and the change of ash
concentrations were significant only in rats on the L diet. In
rats fed the G, F or L diet, significantly more lipid accu-
mulated in the liver than in the starch-fed control rats. The
order of magnitude of liver fat content was starch < glucose,
< fructose and < lard (Table 2 and Fig. 3). In rats fed the G
and F diets, lipid accumulation in the liver was likely due to
the increased level of de novo lipogenesis.
Fallon and Kemp (1968) obtained a similar result when
investigating hepatic lipid synthesis in liver homogenates
from rats fed a high-carbohydrate diet and a diet high in
corn oil. They concluded that ‘high-carbohydrate diets fed to
rats for 6 days increased the triglyceride synthesis’. Diets
high in starch were less effective than diets containing high
levels of glucose, sucrose, or fructose. Corn oil did not alter
the TG synthesis of hepatocytes. It is well documented that
dietary fructose, sucrose and high-fructose corn syrup tend
Fig. 3. Effect of diets on the chemical composition of the liver.
Different letters indicate significant differences among the treat-
ment groups at P < 0.05
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to induce fatty liver; however, it was suggested that the
development of fatty liver takes a longer time period (8–24
weeks) (Jensen et al., 2018).
An interesting question that may be asked is why the fat
content of the liver was significantly higher in rats on the G
diet than in the starch-fed control animals; the carbohydrate
content of the diets was similar, and the absorbed carbo-
hydrate was glucose in both cases.
A simple answer might be that in a given unit of time
much more glucose may enter the liver than from the slower
absorbable starch, causing higher intracellular glucose and
triose concentrations as well as increased lipogenesis.
However, Katz and McGarry (1984) suggest that lipid
synthesis in rodents may be due to the fact that ‘the glucose
administration acts mainly as a trigger, but the hexose serves
only indirectly (via lactate or glycogen) as a precursor for this
process in the liver’. Pilkis and Granner (1992) suggest that
the uptake of glucose by hepatocytes is mediated through the
glucose transporter GLUT2, which does not require insulin
for activation. The consequence of this could be that glucose
enters the liver cells without insulin regulation and thereby
may result in very high intracellular glucose concentration.
Glucose is first converted to glycogen and once glycogen
stores are replenished, glucose enters the glycolysis pathway
and thereby provides carbons for the tricarboxylic acid
(TCA) cycles and de novo lipogenesis (Weickert and Pfeiffer,
2006). High glucose and insulin administration have also
been shown to inhibit fatty acid oxidation (Randle, 1998).
It was also interesting to note that the N-free extract
(carbohydrate) content of the liver of rats on G, F or L diets
was lower (–24.9, –17.2 and –59.6%, respectively) than in the
group fed the St diet; however, the difference was statistically
significant only in rats on the L diet.
This is consistent with the data of Remesy et al. (1978),
who conditioned rats to 42 or 79% carbohydrate containing
diets and noted that the portal vein glucose concentration
was 8.8 mM in the rats eating the 42% carbohydrate diet but
net hepatic glucose output was still positive. Animals
consuming the high-carbohydrate diet exhibited hepatic
glucose uptake, which was at the expense of a much higher
portal vein glucose concentration (13.6 mM).
According to Merino et al. (2020), fructose is transported
by GLUT5 through the brush border membrane. In the
cytosol of enterocytes, it is rapidly phosphorylated by KHK-
C, leading to a rapid depletion of intracellular ATP level. A
pool of phosphorylated fructose is partially or totally
metabolised. The non-phosphorylated fructose is released
across the basolateral membrane into the portal circulation
by apical GLUT2. Blakemore et al. (1995) reported that the
GLUT5 transporter is also expressed in the basolateral
membrane of the human intestine, suggesting that non-
phosphorylated fructose can easily pass through the enter-
ocytes and reach the liver, where it can be metabolised.
Hepatic fructose uptake is not regulated and there is no
negative feedback. Because KHK-C phosphorylates fructose
to fructose-1-P, it bypasses the rate-limiting step of glycol-
ysis and yields precursors that can be used for gluconeo-
genesis and de novo lipogenesis.
According to the excellent paper of Jang et al. (2018), the
fate of orally administered fructose depends on the quantity
of consumed fructose. Low doses of fructose (<0.5 g/kg BW)
were ∼90% cleared by the intestine, with only trace amounts
of fructose found in the portal blood; however, elevated
concentrations of glucose, lactate, and glycerate derived
from fructose were noted. In the portal vein, they observed
that most dietary fructose has already been converted into
glucose and various organic acids (lactate, glycerate, TCA
intermediates, and amino acids) which can be good sub-
strates for lipogenesis. Therefore, the effect of low doses of
fructose on the liver lipogenesis may be similar to that of
glucose.
According to Zhao et al. (2020), dietary fructose is
converted to acetate by the gut microbiota, and this supplies
lipogenic acetyl-CoA independently of ATP citrate lyase.
They suggest ‘a two-pronged mechanism that regulates he-
patic lipogenesis, in which fructolysis within hepatocytes
provides a signal to promote the expression of lipogenic
genes, and the generation of microbial acetate feeds lipo-
genic pools of acetyl CoA’.
This speculation is in line with that reported here and the
findings of Johnston et al. (2013) who reported that there
was no difference between the effects of high-fructose and
high-glucose diets on liver triacylglycerol or biochemistry in
healthy overweight men. High doses of fructose (≥1 g/kg
BW) overwhelm intestinal fructose absorption and clear-
ance, resulting in fructose reaching both the liver and the
colonic microbiota.
Fructose also rapidly decreases the intracellular adenylate
energy charge (AEC) (ATP þ 0.5 ADP þ ATP þ ADP þ
AMP), resulting in increased uric acid production due to the
activation of AMP deaminase (Khitan and Kim, 2013). Son
et al. (2020) reported that serum uric acid levels were
positively associated with the dyslipidaemia components of
serum, e.g. total cholesterol, TG and LDL cholesterol (LDL-
C) levels, whereas serum HDL-C levels were inversely
related. The fructose-induced depletion of liver adenine
nucleotides inhibited protein synthesis in the liver (M€aenp€a€a
et al., 1968), suggesting that apoprotein synthesis may also
be inhibited and the ineffective packing of TG into nascent
very low density lipoprotein (VLDL) may be a factor in the
pathomechanism of fructose-induced liver steatosis.
Reviewing isotopic tracer studies, Sun and Empie (2012)
concluded that although fructose is a potent lipogenic sub-
strate, the observed fat synthesis from fructose carbons is
quantitatively minor compared with other pathways of
fructose disposal. Only 0.05% and 0.15% of fructose was
converted to de novo fatty acids and TG-glycerol at 4 h,
respectively. The origin of the hepatic lipids in rats fed the
fructose diet remains to be determined.
As Table 2 and Fig. 3 show, the L diet induced almost
three times more lipid in the liver than the St diet. The liver
derives fatty acids primarily from three sources: uptake of
free fatty acids (FFAs) from the blood, chylomicron remnant
uptake, and de novo lipogenesis.
In this study, the most important factor of lipid accu-
mulation in the liver was noted in the high-fat L diet (lard
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45.2% þ corn oil 7.8%) without carbohydrate. Because the
absorbed triglycerides bypass the liver, entering the systemic
circulation directly by the lymphatic circulation, the high
serum and liver TG concentration probably originates from
chylomicron remnants and esterified and non-esterified fatty
acids.
High-fat diets strongly inhibit hepatic lipogenesis and
contribute to the accumulation of TG in the liver (Ferra-
mosca, 2014). Liu et al. (2015) reported that a high-fat diet
induced markedly higher total FFA serum concentration
compared to the control diet in the fed state. In an earlier
experiment, Bruckner et al. (1998) demonstrated that a
diet low in n-3 essential fatty acids and a poor-quality
protein in the diets of cats were required to induce hepatic
lipidosis, suggesting that both protein quality and fatty acid
composition of the diet may play a significant role in the
pathomechanism of fatty liver syndrome. In rates fed a
fructose diet, citrulline supplementation prevented hyper-
triglyceridaemia and attenuated liver fat accumulation
(Jegathesan et al., 2015).
Specific effects of macronutrients on serum
metabolites and hormones
Serum glucose. Table 2 and Fig. 4 show the effect of mac-
ronutrients on serum metabolites. The G, F and L diets
significantly increased the postprandial serum glucose level
over the value of rats on a St diet (glucose: þ29.6%, fructose:
þ10.3% and lard: þ11.6%).
According to Wang et al. (2010), the average post-
prandial blood glucose concentration of normal Wistar rats
is in the range between 5.65 mmol/L and 7.90 mmol/L.
Assuming a 40% haematocrit, this value corresponds to 9.4
± 2.72 and 13.2 mmol/L serum glucose concentrations
(Amara et al., 2018). Therefore, the postprandial serum
glucose concentrations in the current study were in the
normal range (St: 7.58 ± 1.23, G: 9.82 ± 3.11, F: 8.36 ± 1.51
and L: 8.45 ± 1.27 mmol/L serum).
Serum fructosamine. Fructosamine determines the glycated
fraction of total serum protein and reflects one- to two-week
changes in blood glucose. Figure 4 shows that neither the G
nor the L diet influenced the fructosamine level significantly.
However, the F diet decreased it significantly (–12.5%),
suggesting that a 4-week feeding of these nutrients was not
long enough to damage, or interfere with, carbohydrate
metabolism. Another explanation may be that when
balanced diets are fed, as in the current experiment, the
negative effect of F or L on carbohydrate metabolism is
minimal or does not occur.
Serum cholesterol. G significantly (P < 0.05) decreased
(–19.9%) and L significantly (P < 0.05) increased (þ32.3%)
the total cholesterol level of the serum, but F did not change
it relative to the St control group (Fig. 4). Other researchers
have also reported similar results for fructose (Mamikutty
et al., 2014; K€oseler et al., 2018).
Serum triglyceride. In current study, both the G and the F
diets increased, while the L diet decreased the serum TG
level significantly (P < 0.05) (Fig. 4). This is substantiated by
the findings of others (Nishina et al., 1993) in that mice
normally have low plasma TG levels which are further
lowered by high-fat diets. According to Byers and Friedman
(1960), the liver is the major source of plasma TG. Schaefer
et al. (2009) suggested that dietary glucose and fructose
differentially affected lipid and glucose homeostasis; they
mention that in short-term controlled feeding studies,
fructose significantly increased postprandial TG levels and
had little effect on serum glucose concentrations, whereas
dietary glucose had the opposite effects.
Serum LDH. The serum LDH activity was determined in
this study in order to see if the diets have a hepatotoxic effect
(Table 2). Figure 4 shows the relative changes of LDH ac-
tivity compared to the St control group. G slightly decreased,
while F slightly increased serum LDH activity, but neither of
these changes were significant. The difference between the G
and the F groups is close to the significant level (P 5 0.11).
This suggests that the F diet induced no cell damage during
the four-week feeding period. The L diet significantly
decreased the LDH activity, suggesting that during this
experimental time period lard had no toxic effect on the
liver.
Serum insulin. The data of Table 2 and Fig. 4 show that
relative to the St diet, neither the G nor the F diet had sig-
nificant effects on the serum insulin concentration; however,
in the latter group serum insulin was 47.7% higher than the
control value and close to the significant level (P 5 0.105).
The L diet significantly (–8.8%; P < 0.05) decreased serum
insulin. This result is consistent with the data reported in a
previous experiment with cold-stressed rats (Szabo et al.,
2018), notably that safflower oil reduced plasma insulin
concentration compared to both fasted rats and rats fed a
balanced diet. Zavaroni et al. (1980) reported similar find-
ings in rats feed fructose for 7 days, which resulted in an
increase in the insulin response to an oral carbohydrate
challenge, as well as to a loss of normal insulin sensitivity.
Fig. 4. Specific effects of the St, G, F and L diets on serum me-
tabolites and hormones. Different letters indicate significant dif-
ferences among the treatment groups at P < 0.05
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Serum glucagon. As shown in Table 2 and Fig. 4, the G diet
decreased while the F and the L diets significantly increased
the serum glucagon concentration. In the rats fed diet F the
serum glucose and insulin concentrations were also
increased, suggesting early signs of insulin resistance. This is
supported by the opinion of Elliott et al. (2002) that fructose
causes insulin resistance syndrome. Another mechanism
that may be involved is that alpha cells have GLUT5
transporters (Sato et al., 1996) and KHK enzyme (Giroix
et al., 2006), the fructose entering the alpha cells is rapidly
phosphorylated and thus may acutely deplete ATP and
inorganic phosphate (Pi) resulting in a cytosolic energy
deficit, which may in turn trigger glucagon release. The L
diet also increased glucagon concentration.
In contrast to this, in a previous experiment with cold-
stressed rats, safflower oil significantly decreased the plasma
glucagon concentration. The exact effects of lipids on plasma
glucagon concentration are unclear since both inhibitory
and stimulatory effects have been reported by others
(Edwards et al., 1969; Gilon et al., 2014). Most likely the
environment and the dietary fatty acid composition of the
fat fed may explain some of these opposing findings.
Serum leptin. In this experiment the G and L diets increased,
while the F diet decreased the postprandial leptin concen-
tration of the serum (Table 2 and Fig. 4). As opposed to the
current study, Jian-Mei et al. (2008) reported that fructose
consumption significantly increased the serum leptin and uric
acid levels in rats and induced a significant increase of leptin
secretion by upregulating the expression of the obese (ob)
gene in adipose tissue. Quercetin and rutin (plant flavonoids,
antioxidants), as well as allopurinol reduced hyper-
leptinaemia and inhibited leptin secretion from adipose tis-
sue. Like in the current study, they also found increased
serum insulin concentration. Others (Shapiro et al., 2008)
reported that chronic fructose consumption caused leptin
resistance, while serum leptin levels, weight, and adiposity
were the same as in the leptin-responsive control rats.
Insulin/glucagon (I/G), insulin/leptin (I/L) and glucagon/
leptin (G/L) ratios. Three hormonal ratios were calculated
from the serum hormone concentrations to better under-
stand their interrelationships. Figure 5 clearly shows that
G and F have different effects on I/G, I/L and G/L ratios,
which indicates that although fructose and glucose carry the
same quantity of gross energy, they have different hormonal
effects. Glucose elicits an anabolic hormonal response, while
fructose has an indirect catabolic effect by the small I/G and
high I/L and G/L ratios. G and L diets also have different
effects on the I/G and G/L ratios. However, in the case of the
L diet, the synthetic pathways may also be inhibited by the
low insulin and high glucagon levels.
Specific effects of the St, G, F, and L diets on the
immune response and the microbiota
Immune response. To better understand the interrelation-
ship between the nutrients and the immune response of an
organism, its physiology, metabolism and the changes of the
intestinal microbiota have to be considered. In this experi-
ment, the nutrients did not have a significant effect on the
humoral immune response by the 14th day after the first
immunisation (Table 2 and Fig. 6).
However, after the second immunisation, by the 30th day
of the experiment, the G diet increased, while the F and L
diets significantly decreased the antibody titre. In an earlier
experiment, Szabo et al. (2018) demonstrated that glucagon
correlated significantly with the serum glucocorticoid level
(not determined in this experiment). The immunosuppres-
sive effect of increased glucagon (Kevorkov et al., 1987) and
corticosterone (Coutinho and Chapman, 2011) concentra-
tion may explain the lower serum antibody titre in the rats
fed the F diet. This is also supported by other authors who
reported that the feeding of high-fructose (Prince et al.,
2017) or high-fat (Namvar et al., 2016) diets was associated
with elevated levels of corticosterone.
Akkermansia and Escherichia were correlated positively
(r 5 0.964 and 0.960, respectively) and Fusobacterium
negatively (r 5 –0.972) to the serum antibody titre, sug-
gesting that there is a balance between the stimulating and
inhibiting effects of the microflora on the immune function
(Fig. 6).
The association between the gut microbiota and immu-
nity has been shown to influence the development of major
Fig. 5. Effect of diets on insulin per glucagon (I/G), insulin per
leptin (I/L) and glucagon per leptin (G/L) ratios
Fig. 6. Effect of diets on serum glucagon, antibody titre and the
genera Fusobacterium, Escherichia, and Akkermansia (dotted lines
do not indicate a continuum)
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components of the host’s innate and adaptive immune sys-
tem and may contribute to the pathogenesis of immune-
mediated disorders (Zheng et al., 2020).
It was reported that certain fusobacteria can inhibit hu-
man T-cell responses (Nsho et al., 2016). For example,
Fusobacterium nucleatum may mediate the initiation and
progression of colorectal cancer by inhibiting host anti-
tumour immunity (Borroni et al., 2019).
It is clear from these data that nutrients can significantly
influence the host organism’s actual concentration of hor-
mones, its metabolism, the intestinal microbiota, and the
immune response. Further studies should be carried out to
determine these interrelationships and to administer
appropriate nutrients in accordance with the therapeutic
goals.
Effect of the St, G, F, and L diets on the microbiota. The
effects of the St, G, F, and L diets on the taxonomic diversity
of the microbiota, at different levels of taxonomy, is pre-
sented in Table 3. A very conspicuous difference is noted in
the total number of reads per g of caecal content for glucose,
fructose, or lard diets (39,056, 30,141 and 30,610, respec-
tively), where the reads were twice as high as in the starch-
fed group (14,924). At the different taxonomic levels (genus,
family, order, class, phylum) the diversity was generally
lower in rats fed the fructose diet compared to the glucose-
and the lard-fed groups (Table 3).
Table 3 also indicates that there are significant differ-
ences in the number of phyla detected in the caecal contents
of the rats fed the St, G, F and L diets (26, 35, 35 and 28,
respectively). The Shannon diversity index was 4.526, 4.069,
3.347 and 4.275 for the St, G, F and L diets, respectively.
In the rats fed the G diet, the operational taxonomic
units (OTUs) of the five most abundant phyla were
increased, while F feeding increased only Firmicutes and
Bacteroidetes and decreased the other three phyla (Fig. 7).
The effect of L on Firmicutes and Bacteroidetes was similar
to that seen in rats fed the G diet; however, the OTUs of
Verrucomicrobia decreased similarly as in the F group.
Furthermore, the L diet increased the number of OTUs in
Proteobacteria (þ47%) and Actinobacteria (þ64%). Figure 7
shows that depending on the manner in which the data are
expressed (abundance or relative abundance), different re-
sults may be obtained.
If the data are expressed as relative abundance (Table 4
and Fig. 7), the sum of the reads represents 100% in each
treatment group.
The phyla Firmicutes, Bacteroidetes, Verrucomicrobia,
Proteobacteria and Actinobacteria represented 97.54, 98.48,
98.47 and 97.55% of the entire genome for St, G, F and L
diets, respectively.
Firmicutes and Bacteroidetes were the two predominant
phyla, contributing 39.9% and 37.83% in the St group,
26.69% and 51.94% in the G group, 48.32% and 43.92% in
the F group, and 28.67% and 59.35% in the L group,
respectively. Verrucomicrobia, Proteobacteria and Actino-
bacteria were the next three most dominant phyla, ac-
counting for 9.21%, 8.31% and 2.29% in the St group,
10.98%, 7.43% and 1.43% in the G group, 1.75%, 3.57% and
0.91% in the F group, and 1.75%, 5.94% and 1.83% in the L
group, respectively.
Figure 7 indicates that, as compared to the St diet, the G
and the L diets decreased, while the F diet increased the
proportion of Firmicutes. In contrast, the G, F and L diets
increased the relative proportion of Bacteroidetes in the
entire genome. The Verrucomicrobia/Firmicutes ratio was
increased slightly by the G diet and decreased dramatically
by the F and L diets. The direction of the dietary effects on
the phyla Proteobacteria and Actinobacteria was negative
and more or less identical.
Another possibility for evaluating the effect of diets on
the microbiota is to calculate the ratios of the different phyla
to Firmicutes (Fig. 8). According to this interpretation, the
effects of starch and glucose are very similar and the trend,
when comparing fructose and lard diets, is also similar;
however, the magnitudes of the ratio changes were different.
The lowest ratios to Firmicutes were those of Verruco-
microbia and Proteobacteria in the F and L groups. The
Fig. 7. Effect of the St, G, F and L diets on the caecal microbiota. Depending on how the data are expressed (abundance or relative
abundance), different results may be obtained
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Bacteroidetes to Firmicutes ratios were similar in the St and
F or the G and L groups.
Figure 9 depicts the effects of the experimental diets on
the relative proportions of different genera in the caecal
microbiota. Compared to St, G and L decreased, while F
increased the proportion of Lactobacillus.
The numbers of Bacteroides, Alistipes, Butyricimonas and
Phascolarctobacterium were increased by the G and L diets.
F slightly increased the proportion of Bacteroides but did not
markedly influence Alistipes and Butyricimonas; however, F
decreased the proportions of Parabacteroides and Phasco-
larctobacterium in the caecal microbiota. G increased but F
and L decreased the proportion of Akkermansia and
Escherichia in the caecal microbiota.
The G, F, and L diets decreased the proportions of
Ruminococcus, Eubacterium, Streptococcus, Clostridioides,
Clostridium and Muribaculum. G and F decreased the
proportions of Lachnoclostridium and Oscillibacter, while L
did not influence these genera. F decreased, but G and L did
not influence the proportions of Blautia. The effects of diets
on the microbiota are numerous and interpretation of the
effect of these changes on physiologic, biochemical, and
clinical outcomes will require further studies.
A constructed heatmap diagram of two-way hierarchical
clustering analysis consisted of the four treatment groups on
the genus level of microbiota (Fig. 10). According to this, the
microbiota of rats fed G and L diets was more closely related,
while St and F diets were hierarchically farther away. When
comparing the different carbohydrate diets, the G and F
diets affect the microbiota quite differently than the St diet
fed in the control group. Glucose and fructose appear to
attenuate many of the microbiota genera compared to
starch. It is evident from the variability of the data, as pre-
sented by the different calculations, that different outcomes
might be concluded.
Connections among the caecal microbiota and the studied
clinical parameters. To begin understanding which clinical
indicators might be related to the microbiota changes,
network analysis and centrality (weight of connected nodes)
were used to ascertain the possible correlations between the
microbiota and the clinical indicators studied.
Correlations among the microbiota, feed and energy
intake, body weights and abdominal white adipose tis-
sues. The feed intake, energy intake, BW gain, EVSCBW,
feed/gain, epididymal and retroperitoneal fat pads and the
microbes significantly correlating with these parameters are
indicated in Fig. 11.
Centrality analysis showed that the retroperitoneal fat
pad and the EVSCBW are the two most important nodes in
Table 3. Effect of the starch, glucose, fructose, and lard diets on the diversity of operational taxonomic units (OTUs)/gram caecal content
Number of OTUs/gram caecal content
Starch Glucose Fructose Lard
Shannon diversity indexp 4.526 4.069 3.347 4.275
Total reads 14,924 39,056 30,141 30,610
Genus 732 883 676 851
Family 295 329 286 302
Order 145 152 138 141
Class 73 69 64 68
Phylum 26 35 35 38
Number of OTUs/g caecal content at the phylum level
Firmicutes 5,953 10,425 14,564 8,777
Bacteroidetes 5,647 20,285 13,238 18,168
Verrucomicrobia 1,374 4,288 528 536
Proteobacteria 1,241 2,903 1,076 1,819
Actinobacteria 342 560 275 561
Ratios to Firmicutes
Firmicutes/Bacteroidetes 1.05 0.51 1.10 0.48
Firmicutes/Verrucomicrobia 4.33 2.43 27.58 16.38
Firmicutes/Proteobacteria 4.80 3.59 13.54 4.83
Firmicutes/Actinobacteria 17.41 18.62 52.96 15.65
pThe Shannon diversity index is commonly used to characterise species diversity in a community. The value depends on the number of
species – the more species, the higher the diversity.
Fig. 8. Phylum ratios based on the relative abundance of opera-
tional taxonomic units (OTUs)
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this network, influencing the network both positively and
negatively. It is well known that adipose tissues play sig-
nificant roles in controlling metabolism, e.g. they are
important regulators of energy and glucose metabolism and
act as endocrine organs secreting bioactive substances and
hormones (Lou and Liu, 2016).
The negative correlations of the epididymal and retro-
peritoneal adipose tissues with EVSCBW are also anticipated
because there is a known crosstalk between skeletal muscle
and adipose tissue metabolism (Argiles et al., 2005), and
visceral obesity is known to be associated with the loss of
skeletal muscle mass (Kim et al., 2014). Alistipes, Para-
bacteroides and Morganella also occupy a relatively high
position in this network. They show positive relationships
with energy intake, BW gain and retroperitoneal fat pads,
and negative relations with feed intake and EVSCBW. These
Table 4. Relative abundance of operational taxonomic units (OTUs)
Phylum
Starch (St) Glucose (G) Fructose (F) Lard (L)
Criteria of reduction
At least 1 genus OTU in each treatment group
Firmicutes 39.889 26.692 48.320 28.674
Bacteroidetes 37.838 51.938 43.920 59.353
Verrucomicrobia 9.207 10.979 1.752 1.751
Proteobacteria 8.315 7.433 3.570 5.943
Actinobacteria 2.292 1.434 0.912 1.833
Per cent of entire genome 97.54 98.48 98.47 97.55
More than 0.1% relative phylum abundance in the starch control group
Cyanobacteria 0.402 0.269 0.149 0.268
Tenericutes 0.369 0.207 0.129 0.121
Spirochaetes 0.348 0.172 0.103 0.258
Euryarchaeota 0.281 0.179 0.076 0.199
Fusobacteria 0.275 0.195 0.697 0.947
Chloroflexi 0.181 0.064 0.027 0.085
Deinococcus-Thermus 0.101 0.049 0.060 0.049
Per cent of entire genome 99.50 99.61 99.71 99.48
At least 1 phylum OTU in each treatment group
Chlorobi 0.074 0.061 0.043 0.085
Aquificae 0.074 0.031 0.007 0.036
Synergistetes 0.060 0.041 0.043 0.069
Acidobacteria 0.047 0.033 0.013 0.033
Thermotogae 0.047 0.038 0.036 0.029
Planctomycetes 0.040 0.044 0.043 0.039
Chlamydiae 0.027 0.010 0.020 0.036
Deferribacteres 0.020 0.013 0.010 0.023
Chrysiogenetes 0.020 0.003 0.003 0.007
Thaumarchaeota 0.020 0.010 0.003 0.003
Crenarchaeota 0.013 0.008 0.010 0.029
Nitrospirae 0.013 0.010 0.003 0.010
Balneolaeota 0.013 0.010 0.010 0.003
Ignavibacteriae 0.007 0.020 0.003 0.029
Gemmatimonadetes 0.007 0.003 0.003 0.020
Fibrobacteres 0.007 0.005 0.003 0.010
Per cent of entire genome 99.99 99.95 99.97 99.94
The rest of the entire genome
Calditrichaeota 0.007 0.013 0.003 –
Dictyoglomi 0.007 0.008 – –
Elusimicrobia – 0.005 0.003 0.010
Kiritimatiellaeota – – 0.003 0.010
Armatimonadetes – 0.003 0.010 0.007
Thermodesulfobacteria – 0.008 0.003 0.007
Candidatus Cloacimonetes – – 0.003 0.007
Candidatus Gracilibacteria – 0.003 0.000 0.007
Coprothermobacterota – 0.005 0.003 0.003
Negarnaviricota – 0.005 – 0.003
Caldiserica – – – 0.003
Candidatus Korarchaeota – – – 0.003
Per cent of entire genome 100.00 100.00 100.00 100.00
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results are similar to those reported by Zeng et al. (2019).
They studied the microbiota of obese and healthy patients
and found six gut microbiota markers of obesity, namely the
alteration of Bacteroides, Parabacteroides, Blautia, Alistipes,
Romboustia and Roseburia. In our rat model, Adlercreutzia,
Alistipes, Parabacteroides, Petrimonas and Morganella
showed positive or negative correlations with the obesity-
related parameters.
Correlations and centrality of the microbiota and organ
weights. In the current experiment, the correlation and
centrality analysis revealed several possible correlations be-
tween the organ weights and the microbiota. Analysis at the
genus level revealed two clubs of nodes with positive or
negative connections with the microbiota (Fig. 12).
The members of the first small club are the kidney
weights and three genera that show positive (Lactobacillus)
and negative (Proteiniphilum and Butyricimonas) correla-
tions with the weight of the kidney. Several pathological or
beneficial effects of the microbiota on the liver (Brenner
et al., 2015), kidney (Ramezani and Raj, 2014), cardiovas-
cular (Tang et al., 2017) and metabolic diseases (Pascale
et al., 2018) have been reported. We hypothesised a bidi-
rectional relationship with positive and negative effects on
each other.
This hypothesis is strengthened by the clinical outcomes
that alterations in the microbiota may also affect
kidney disease in both a positive and a negative direction
and, furthermore, the abnormally functioning kidney
may disrupt a balanced microbiota (Al Khodor and Shatat,
2017).
The second large club of networks indicates the rela-
tionship among the weights of spleen, liver and adrenals
with the members of the caecal microbiota at the genus level.
According to centrality analysis the spleen, the liver and the
adrenals are in the centre of this second club of the network,
showing primarily negative relations with members of the
microbiota.
Correlations among the microbiota and metabolomics
at genus level. In this network (Fig. 13) four smaller and
one large club of nodes can be distinguished. The first is the
insulin/glucagon ratio with three microbes (Pseudomonas,
Orella and Morganella).
Fig. 9. Specific effect of the G, F and L diets on the caecal microbiota in genera representing 99% of the caecal microbiota
Fig. 10. Heatmap diagram of two-way hierarchical clustering
analysis consisting of four treatment groups and 60 genera of the
caecal microbiota of rats. The red colour represents an expression
level above mean, while the blue colour represents an expression
lower than the mean. On the vertical left side, the hierarchical
cluster of the genera is indicated. Bottom labelling shows the
treatment groups
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The second club includes serum glucagon, antibody titre,
Escherichia, Akkermansia and Fusobacterium. Gram-nega-
tive microbes containing LPS in their outer membrane are
known to play a significant role in the immune response of
the host organism, promote pro-inflammatory cytokines,
nitric oxide and eicosanoids (Abbas et al., 2012). Antibody
titre showed a negative correlation with serum glucagon and
Fusobacterium but a positive correlation with Escherichia
and Akkermansia. It is well known that the antibody titre is
influenced by commensal and pathogenic intestinal mi-
crobes (Belkaid and Hand, 2014).
It is believed that Akkermansia muciniphila protects
against obesity and augments antitumour responses
(Ansaldo et al., 2019). In contrast, Fusobacterium nucleatum
suppresses anti-tumour immunity (Gur et al., 2019). More
research is needed to unravel the significance of these in-
terrelationships.
The third club includes the glucagon/leptin ratio, Pas-
teurella and Tenerella. There is a strong positive correlation
between Pasteurella and serum fructosamine and since
fructosamine is positively correlated with glucagon/leptin,
these correlations may be associated with increased risk for
cardiovascular disease and energy expenditure.
The fourth club contains serum glucose with negative
correlations with Desulfovibrio and Paeniclostridium.
The fifth club includes serum triglyceride, serum insulin,
insulin/leptin, serum leptin and serum LDH with the
depicted microbiota. While all of the genera listed in Fig. 13
have negative correlations with serum triglyceride, there are
both positive and negative correlations with serum insulin
and the microbiota, e.g. Faecalbaculum, Enterococcus and
Lactobacillus are positively correlated, while Selenomonas
and Proteiniphilum are negatively correlated. While these
correlations do not indicate cause and effect, they are useful
in possibly interpreting how dietary changes in the micro-
biota might influence, or can be influenced by, clinical
markers and related clinical conditions.
Correlations among the microbiota and metabolomics
at the phylum level. Figure 14 shows the correlations and
centrality of all studied parameters and the microbiota at the
phylum level. It is interesting to note that while Firmicutes and
Bacteroidetes are the predominant phyla associated with the
caecal microbiota, they did not correlate significantly with each
other (r 5 –0.729), nor with the feed and energy intake, BW
gain, abdominal white adipose tissues, and serum metabolites.
The only exception was that the phylum Bacteroidetes
was negatively correlated with liver N-free extracts (r 5
–0.962). This latter relationship suggests that nutrients
increasing the glucose and glycogen content of the liver may
also be in a negative correlation with Bacteroidetes. It is also
known that the microbiota of obese individuals possesses a
lower proportion of Bacteroidetes than that of the lean
control (Clarke et al., 2012).
Fig. 11. Correlations among the feed and energy intake, eviscerated body weight (EVSCBW), abdominal fat pads and caecal microbiota at
the genus level. Centrality indices (framed numbers) quantify the importance of a node in a given network
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It is also clear from the correlation analysis at the
phylum or genus levels that the lower taxonomic levels (i.e.,
genus) yield more information about the specific crosstalk
between the host organism, diet, and the microbiota under
both healthy and pathological conditions.
Summary of the specific effects of the G, F or L diets
Table 5 summarises the direction of the significant changes
induced by the experimental diets. Three out of the 13 pa-
rameters showing a significant change in the rats fed the G
diet, namely the decrease of serum glucagon, leptin and
glucagon/leptin ratio, were glucose-specific effects.
Relative to the data of rats on the St diet, the F diet
changed significantly 17 clinical parameters and only six of
them (the increased spleen and kidney weights, insulin/
leptin and glucagon/leptin ratios, the decreased serum
fructosamine and leptin concentrations) were effects specific
to the F diet.
Among the 22 significantly changed parameters of rats
fed the L diet, fifteen (the increased energy intake, BW gain
and EVSCBW, the weights of the epididymal and retro-
peritoneal fat pads, the serum cholesterol level, the decreased
feed intake, feed/gain ratio, weight of the kidney, ash and N-
free extract content of the liver, insulin/leptin ratio, serum
TG, insulin, and insulin/glucagon ratio) were changes spe-
cific to the L diet.
An interesting observation was that in rats fed the F diet,
the weight of the epididymal (increased) and retroperitoneal
(decreased) fat depot changed in the opposite directions, and
the difference between them was statistically significant.
Speculations why fructose may be toxic
Based on the cited literature and our experimental data
summarised in Table 5, the following general speculations
and conclusions may be drawn:
1. We assume that the effects of fructose depend on the
form in which it is presented, e.g., injected or per os,
administered in liquid or solid form, disaccharide vs.
monosaccharide, alone or with other nutrients.
The reason for the different affects of fructose adminis-
tered in soft drinks compared to dry diets may be due to the
higher dose administered in a given unit of time, the rapidity
of absorption from the small intestine and the high con-
centration of fructose reaching the hepatocytes in a given
unit of time.
2. The effect of a fructose diet may also depend on the
gastric transit time and the ratio of other macronutri-
ents in the diet. Fat, for example, slows down the gastric
transit time, resulting in less fructose to be absorbed
from the small intestine in a unit of time and lower
fructose concentration in the liver. In the different
Fig. 12. Significant correlations and centrality indices (weight of connected nodes) among organ weights and caecal microbiota at the genus
level. Centrality indices (framed numbers) quantify the importance of a node in a given network
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tissues having GLUT5 transporters and KHKC enzymes
(e.g., enterocytes, hepatocytes, kidney cells), fructose is
rapidly phosphorylated and bypasses the phosphofruc-
tokinase regulatory step in glycolysis. Only the rate, the
rapidity, the dose, and the duration of the fructose load
determines whether the administered fructose can pass
through the shields of enterocytes and hepatocytes, and
therefore this determines whether or not it will be toxic.
Fructose, upon reaching the systemic circulation and the
peripheral cells, may influence their metabolism
depending on whether they have a GLUT5 transporter
and on the type of KHK enzymes.
3. The consequences of a high intake of fructose include an
immediate increase of hepatic glucose, pyruvate, and
lactate production via the activation of pyruvate dehy-
drogenase, the esterification of nonesterified fatty acids,
the increase of adenine nucleotide degradation and
thereby accelerated uric acid formation with subsequent
hyperuricaemia (Mayes, 1993). Hyperuricaemia may
contribute to pancreatic beta cell dysfunction and death
and may be implicated in the development of type 2
diabetes mellitus (Johnstone, 2015; Caliceti et al., 2017).
4. The increased triose pool induces glycogen and lipid
synthesis as long as the decrease of cytosolic adenylate
energy charge (AEC) 5 (ATP þ 0.5 ADP þ ATP þ
ADP þ AMP) makes this possible. The physiological
values of energy charge are somewhere between AEC 5
0.7 and AEC 5 0.95, stabilising at a value of 0.9 (De la
Fuente et al., 2014). In a severely energy-depleted con-
dition, the AEC drops, resulting in cell death. Chapman
et al. (1972) suggested that ‘growth can occur only at
energy charge values above 0.8, and that viability is
Fig. 13. Significant correlations and centrality indices (weight of connected nodes) of serum parameters and caecal microbiota at the genus
level. Centrality indices (framed numbers) quantify the importance of a node in a given network
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Fig. 14. Significant correlations and centrality indices (weight of connected nodes) among caecal microbiota and the measured parameters at
the phylum level. Dashed line indicates non-significant correlations. Centrality indices (framed numbers) quantify the importance of a node
in a given network
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maintained at values between 0.5 and 0.8, and that cell
death occurs at values below 0.5’. This, together with the
lipid accumulation, may be the first step leading to fatty
liver and subsequent cirrhosis.
5. Itoh (1983) orally administered fructose to rats. The
AEC of control rats was 0.74 ± 0.02 and after the
administration of fructose the AEC decreased to 0.5
within 2 min. In case of glucose administration, a
similar effect was observed, however the magnitude of
change was much less. In case of low energy charge the
energy-dependent cytosolic synthetic pathways can be
inhibited. This is consistent with the findings of Chong
et al. (2007), in that, under acute postprandial condi-
tions, little activity from radiolabelled fructose showed
up in the fatty acid portion of triacylglycerols (TAG),
that is, ‘fatty acids are primarily from endogenous fat’;
also, the incorporation of DL-leucine-1-(14)C into liver
protein is almost completely inhibited (M€aenp€a€a et al.,
1968). The inhibition of lipid oxidation and of apo-
protein synthesis, necessary for the lipid export, may
result in liver lipid accumulation. Excess fructose con-
sumption also affects extra hepatic adipocytes by
favouring increased glutamate and fatty acid synthesis
and release (Varma et al., 2015). Fructose, that is not
absorbed, is a good substrate for volatile fatty acid
(VFA) synthesis by the gut microbiota and the absorbed
acetate is also a good substrate for hepatic lipid syn-
thesis (Zhao et al., 2020).
6. On this basis, the following fructose paradox hypothesis
may be presented: despite a high cytosolic triose con-
centration, ADP is not resynthesised to ATP. The
resynthesis may not occur because of the following:
a. The phosphorylation of fructose by the fructokinase
reaction is rapid, whereas the aldolase B reaction is
relatively slow (Champe and Harvey, 1987); the
lowered availability of Pi limits the rate of ATP
resynthesis. Nishi et al. (1989) have shown that
perfusion of the liver with a high fructose concen-
tration (>2 mM) causes the accumulation of fructose-
1-P and the depletion of Pi.
b. Fructose impairs the mitochondrial respiration in
hepatocytes by decreasing the activities of aconitase
and GOT by 35% and 47%, respectively (Madlala
et al., 2018).
c. The depletion of ATP stimulates AMP deaminase
leading to uric acid and Pi release. The consequence
of this is that there is a decrease of intracellular
inorganic phosphate level and this limits the rate of
ADP rephosphorylated to ATP, thus resulting in a
decreased energy charge.
7. The decreased hepatic intracellular energy charge results
in increased uric acid, lactate, and fructose release from
the liver and subsequent lipid synthesis in the peripheral
adipose tissues leading to obesity and hepatotoxicity.
8. In the fructose-loaded liver, the hepatocytes act as
starving cells, sending signals (uric acid and Pi release) to
the pancreatic b-cells and the hypothalamic–pituitary
axis, resulting in increased catabolic hormone secretion
(glucagon and corticosterone) (Szabo et al., 1995).
a. Uric acid-treated mice exhibited significantly impaired
glucose tolerance and lower insulin levels in response
to a glucose challenge as well as an elevated level of
uric acid which caused b-cell injury (Jia et al., 2013).
b. Nakagawa et al. (2006) provided good experimental
evidence for the causal role of uric acid in fructose-
induced metabolic syndrome, by demonstrating that
the inhibition of uric acid formation by allopurinol can
prevent metabolic disorders caused by fructose feeding.
9. Relative to the starch diet, in this study the fructose diet
increased the OTUs of both Firmicutes and Bacter-
oidetes, and decreased the proportions of Actino-
bacteria, Proteobacteria and Verrucomicrobia in the
caecal microbiota.
10. Fructose, which is not absorbed, indirectly influences
liver function by modifying the intestinal microbiota
and thereby the microbial fermentation of fructose to
VFAs providing substrates for lipid synthesis. Dietary
nutrients seem to play a more significant role at the
genus level than at the phylum level, which also likely
changes the ratios of VFAs.
11. Fructose may also increase the absorption and the
plasma level of LPS by altering the Gram-negative
microbial population and thus contributing to inflam-
mation and degradation of the mucosal barrier (Lam-
bertz et al., 2017).
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